The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Journal of Women's Health · 2024-12 · 33 (12) · 1606-1613
DOI: 10.1089/jwh.2024.0033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Women's Health, online erschienen am 02.12.2024. Verfasst von Adele C Viguera und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ammon-Pinizzotto Center for Women's Mental Health, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Postpartum Hemorrhage, Registries, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Previous studies suggest an association between late pregnancy exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) and increased postpartum hemorrhage (PPH) risk. This is the first pregnancy registry study to compare PPH outcomes among women with psychiatric illness exposed or unexposed to SSRIs/SNRIs proximate to delivery.
Methods
This study used data from the National Pregnancy Registry for Psychiatric Medications to evaluate the relationship between SSRI/SNRI exposure in late pregnancy and PPH risk. The sample included n = 953 participants with retrospectively collected medical record data on postpartum blood loss, n = 453 unexposed to SSRIs/SNRIs during pregnancy, and n = 500 exposed at least during the week of delivery. PPH was defined as an estimated blood loss ≥500 mL following vaginal delivery or ≥1,000 mL following cesarean section (C-section), with onset of excessive bleeding occurring within the first 24 hours postpartum. Univariate and multivariate logistic regression analyses were performed to determine odds ratios.
Results
Overall PPH incidence was 13.1%. SSRI/SNRI exposure was associated with a PPH unadjusted odds ratio of 1.42 compared to no exposure (95% confidence interval [CI: 0.97, 2.08]) and an adjusted odds ratio of 1.33 (95% CI [0.90, 1.97]). When stratified by delivery type, the odds ratio following vaginal delivery among women exposed to SSRIs/SNRIs was 1.04 (95% CI [0.63, 1.70]) versus 2.31 (95% CI [1.25, 4.26]) for C-section delivery; the adjusted C-section odds ratio was 2.21 (95% CI [1.18, 4.13]).
Conclusions
Although these findings align with accumulating evidence suggesting SSRI/SNRI exposure may confer a modestly increased risk of PPH, particularly after C-section, the study was underpowered to make definitive conclusions. These preliminary data highlight the need for further research with larger sample sizes. Nevertheless, the findings underscore the importance of greater clinical monitoring for PPH following C-section, especially in women who may have other known PPH risk factors and are exposed to SSRIs/SNRIs in late pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ammon-Pinizzotto Center for Women's Mental Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Cleveland Clinic, Neurological Institute, Cleveland, Ohio, USA.
- School of Public Health, Boston University, Boston, Massachusetts, USA.
- Maternal Mental Health Clinic at Hoag, Newport Beach, California, USA.
- Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Memorial Presbyterian Hospital, Newport Beach, California, USA.
Zitieren
APA
Viguera, A. C., Jones, A., Szpunar, M. J., Bernstein, S. N., Killenberg, P. C., Sojka, E. T., Rossa, E. T., Gaccione, P., Freeman, M. P., & Cohen, L. S. (2024). The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Journal of Women's Health, 33(12), 1606-1613. https://doi.org/10.1089/jwh.2024.0033
Vancouver
Viguera AC, Jones A, Szpunar MJ, Bernstein SN, Killenberg PC, Sojka ET, et al. The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Journal of Women's Health. 2024;33(12):1606-1613. doi:10.1089/jwh.2024.0033
BibTeX
@article{Viguera2024,
author = {Viguera, Adele C and Jones, Alexia and Szpunar, Mercedes J and Bernstein, Sarah N and Killenberg, Parker C and Sojka, Ellen T and Rossa, Ella T and Gaccione, Peter and Freeman, Marlene P and Cohen, Lee S},
title = {The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications},
journal = {Journal of Women's Health},
year = {2024},
volume = {33},
number = {12},
pages = {1606--1613},
doi = {10.1089/jwh.2024.0033}
}
EUVIMED